Clinical Trial Update: Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Velcade (bortezomib) plus dexamethasone, with or without cyclophosphamide or lenalidomide, in multiple myeloma patients who had stabili…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2012-06-08